2023
Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study—December 20, 2020—June 20, 2022
Wang R, Gottlieb M, Montoy J, Rodriguez R, Yu H, Spatz E, Chandler C, Elmore J, Hannikainen P, Chang A, Hill M, Huebinger R, Idris A, Koo K, Li S, McDonald S, Nichol G, O’Laughlin K, Plumb I, Santangelo M, Saydah S, Stephens K, Venkatesh A, Weinstein R, Weinstein R, Gottlieb M, Santangelo M, Koo K, Derden A, Gottlieb M, Gatling K, Guzman D, Yang G, Kaadan M, Hassaballa M, Jerger R, Ahmed Z, Choi M, Venkatesh A, Spatz E, Lin Z, Li S, Yu H, Liu M, Venkatesh A, Spatz E, Ulrich A, Kinsman J, Dorney J, Pierce S, Puente X, Nichol G, Stephens K, Anderson J, Morse D, Adams K, Maat Z, Stober T, O’Laughlin K, Gentile N, Geyer R, Willis M, Ruiz L, Malone K, Park J, Rising K, Kean E, Kelly M, Schaeffer K, Hannikainen P, Shughart L, Shughart H, Renzi N, Amadio G, Grau D, Watts P, Cheng D, Miao J, Shutty C, Charlton A, Hill M, Site R, Chavez S, Kane A, Nikonowicz P, Idris A, McDonald S, Gallegos D, Martin R, Elmore J, Wisk L, L’Hommedieu M, Chandler C, Eguchi M, Roldan K, Villegas N, Moreno R, Rodriguez R, Wang R, Montoy J, Kemball R, Chan V, Chavez C, Wong A, Arreguin M, Plumb I, Hall A, Saydah S, Briggs-Hagen M. Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study—December 20, 2020—June 20, 2022. Open Forum Infectious Diseases 2023, 10: ofad275. PMID: 37426947, PMCID: PMC10327880, DOI: 10.1093/ofid/ofad275.Peer-Reviewed Original ResearchLoss of smellAcute symptomsSARS-CoV-2SARS-CoV-2 positive participantsFrequency of acute symptomsPrevalence of acute symptomsShortness of breathLoss of tasteChest painClinical presentationReport symptomsRespiratory virusesCohort studySevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2SARS-CoV-2 variantsSore throatRespiratory syndrome coronavirus 2Runny noseSyndrome coronavirus 2Coronavirus disease 2019ParticipantsSymptomsCoronavirus 2Omicron
2021
Real-world assessment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nasopharyngeal swab testing in a region with a high burden of coronavirus disease 2019 (COVID-19)
Sangal RB, Peaper DR, Rothenberg C, Fadlallah H, Mobolaji-Lawal M, Landry ML, Sussman LS, Ulrich A, Venkatesh AK. Real-world assessment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nasopharyngeal swab testing in a region with a high burden of coronavirus disease 2019 (COVID-19). Infection Control And Hospital Epidemiology 2021, 43: 1051-1053. PMID: 33823949, PMCID: PMC8111191, DOI: 10.1017/ice.2021.153.Peer-Reviewed Original ResearchEmergency Department Utilization for Emergency Conditions During COVID-19
Venkatesh AK, Janke AT, Shu-Xia L, Rothenberg C, Goyal P, Terry A, Lin M. Emergency Department Utilization for Emergency Conditions During COVID-19. Annals Of Emergency Medicine 2021, 78: 84-91. PMID: 33840512, PMCID: PMC7805390, DOI: 10.1016/j.annemergmed.2021.01.011.Peer-Reviewed Original ResearchConceptsED visitsED visit countsVisit countsClinical Modification codesEmergency department utilizationAcute myocardial infarctionEmergency Department registryCoronavirus disease 2019 (COVID-19) outbreakCoronavirus disease 2019Emergency department (ED) visitationEmergency medical conditionsClinical quality registryTotal visit countsDisease 2019 outbreakCerebrovascular diseaseMyocardial infarctionQuality registryTenth RevisionDisease 2019Medical conditionsEmergency conditionsInternational ClassificationEmergency carePrepandemic levelsDepartment registry
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply